12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Talphera (TLPH) led the gainers with a 10.2% increase, while Atreca (BCEL) saw the largest decline among the losers, dropping 9.6%. Other notable gainers included Biora Therapeutics (BIOR), Vanda Pharma (VNDA), Unity Biotechnology (UBX), Adial Pharmaceuticals (ADIL), and Alaunos Therapeutics (TCRT). On the losing side, Windtree Therapeutics (WINT), Fusion Pharmaceuticals (FUSN), Elicio Therapeutics (ELTX), Shattuck Labs (STTK), and Acutus Medical (AFIB) also saw their stock prices fall.

January 19, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Atreca's stock declined by 9.6% to $0.27, with a market value of $10.7 million.
The notable drop in Atreca's stock price could indicate negative market sentiment, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Adial Pharmaceuticals' shares went up by 4.54% to $1.38, with a market cap of $1.6 million.
The increase in Adial Pharmaceuticals' shares may lead to further short-term interest and potential gains in the stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Biora Therapeutics' shares rose by 8.55% to $0.99, with a market cap of $26.9 million.
Biora Therapeutics' after-market gain could attract more investor interest, potentially leading to a short-term uptrend.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Alaunos Therapeutics' stock rose by 4.48% to $0.12, with a market cap of $29.7 million.
The positive movement in Alaunos Therapeutics' stock price could suggest a short-term bullish trend as investor sentiment improves.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Talphera's stock rose by 10.2% to $0.97, with a market cap of $16.4 million.
The significant after-market gain for Talphera suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Unity Biotechnology's stock moved up by 4.79% to $1.75, with a market cap of $29.3 million.
Unity Biotechnology's after-market rise could be a sign of growing investor interest, possibly leading to short-term price appreciation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Vanda Pharma's stock increased by 4.91% to $3.84, with a market cap of $220.9 million.
The rise in Vanda Pharma's stock price suggests a positive investor response, which may lead to further short-term gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80